Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
63
−14 vs. Q1 2024
Portfolio value
$1.65B
−$1.07B (−39.3%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Redmile Group, LLC in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
TKNOAlpha Teknova, Inc.COM154,509$211.7K<0.1%−16,944−9.9%ReducedHistory
HOOKHOOKIPA Pharma Inc.COM1,063,769$629.5K<0.1%00.0%UnchangedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$697.6K<0.1%00.0%UnchangedHistory
LABStandard Biotools Inc.COM411,631$728.6K<0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.31M0.1%00.0%Unchanged–
KLRSKalaris Therapeutics, Inc.COM1,907,969$1.38M0.1%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM536,682$1.64M0.1%−125,716−19.0%ReducedHistory
XERSXeris Biopharma Holdings, Inc.COM1,046,587$2.35M0.1%00.0%UnchangedHistory
ALLKAllakos Inc.COM3,077,828$3.08M0.2%−373,248−10.8%ReducedHistory
GRTSGritstone bio, Inc.COM5,107,732$3.16M0.2%−647,343−11.2%ReducedHistory
CABACabaletta Bio, Inc.COM442,826$3.31M0.2%00.0%UnchangedHistory
IVVDInvivyd, Inc.COM3,065,714$3.37M0.2%+1,624,989+112.8%AddedHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.73M0.2%00.0%UnchangedHistory
STXSStereotaxis, Inc.COM NEW2,108,219$3.84M0.2%−1,200,579−36.3%ReducedHistory
ATRAAtara Biotherapeutics, Inc.COM NEW452,270$3.84M0.2%+81,738+22.1%AddedConverted for a 1-for-25 splitHistory
BOLDBoundless Bio, Inc.COM1,034,583$4.00M0.2%−79,451−7.1%ReducedHistory
VTYXVentyx Biosciences, Inc.COM2,164,126$5.00M0.3%00.0%UnchangedHistory
CYTKCytokinetics IncCOM NEW111,867$6.06M0.4%−49,733−30.8%ReducedHistory
RPTXRepare Therapeutics Inc.COM1,942,555$6.41M0.4%−73,747−3.7%ReducedHistory
VERVVerve Therapeutics, Inc.COM1,463,406$7.14M0.4%−141,109−8.8%ReducedHistory
ACIUAC Immune SASHS1,807,704$7.21M0.4%−199,327−9.9%ReducedHistory
TRDAEntrada Therapeutics, Inc.COM560,971$7.99M0.5%−722,764−56.3%ReducedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$8.85M0.5%00.0%UnchangedHistory
ESTAEstablishment Labs Holdings Inc.COM213,024$9.68M0.6%+98,683+86.3%AddedHistory
BPMCBlueprint Medicines CorpCOM94,405$10.2M0.6%−18,655−16.5%ReducedHistory
PRMEPrime Medicine, Inc.COM2,074,350$10.7M0.6%00.0%UnchangedHistory
SYKStryker CorpStock39,483$13.4M0.8%−3,763−8.7%ReducedHistory
ARDXArdelyx, Inc.COM1,881,501$13.9M0.8%−313,059−14.3%ReducedHistory
ETNB89bio, Inc.COM1,745,656$14.0M0.8%−518,910−22.9%ReducedHistory
AUGXAugmedix, Inc.COM16,380,327$14.4M0.9%00.0%UnchangedHistory
ISRGIntuitive Surgical IncCOM NEW39,843$17.7M1.1%+10,297+34.9%AddedHistory
IMVTImmunovant, Inc.COM720,177$19.0M1.1%−249,444−25.7%ReducedHistory
IGMSIGM Biosciences, Inc.COM3,072,478$21.1M1.3%00.0%UnchangedHistory
STTKShattuck Labs, Inc.COM5,615,489$21.7M1.3%00.0%UnchangedHistory
FDMT4D Molecular Therapeutics, Inc.COM1,073,435$22.5M1.4%−187,992−14.9%ReducedHistory
ALXOAlx Oncology Holdings IncCOM4,036,451$24.3M1.5%−290,058−6.7%ReducedHistory
KROSKeros Therapeutics, Inc.COM552,506$25.2M1.5%00.0%UnchangedHistory
ABSIAbsci CorpCOM8,253,316$25.4M1.5%00.0%UnchangedHistory
CLDXCelldex Therapeutics, Inc.COM NEW718,723$26.6M1.6%−177,731−19.8%ReducedHistory
IDYAIDEAYA Biosciences, Inc.COM759,516$26.7M1.6%−163,162−17.7%ReducedHistory
BSXBoston Scientific CorpStock390,253$30.1M1.8%−170,673−30.4%ReducedHistory
ANNXAnnexon, Inc.COM6,427,462$31.5M1.9%+924,272+16.8%AddedHistory
CTLTCatalent, Inc.COM595,570$33.5M2.0%−36,894−5.8%ReducedHistory
PLRXPliant Therapeutics, Inc.COM3,209,591$34.5M2.1%+112,371+3.6%AddedHistory
NGNENeurogene Inc.COM1,013,663$36.9M2.2%+78,411+8.4%AddedHistory
BHVNBiohaven Ltd.COM1,087,576$37.7M2.3%−75,665−6.5%ReducedHistory
AKROAkero Therapeutics, Inc.COM1,614,473$37.9M2.3%−244,229−13.1%ReducedHistory
SLNSilence Therapeutics plcADS2,014,296$38.3M2.3%−13,373−0.7%ReducedHistory
BEAMBeam Therapeutics Inc.COM1,703,061$39.9M2.4%−176,556−9.4%ReducedHistory
COGTCogent Biosciences, Inc.COM4,799,973$40.5M2.4%+837,371+21.1%AddedHistory
FATEFate Therapeutics IncCOM13,169,057$43.2M2.6%00.0%UnchangedHistory
ZYMEZymeworks Inc.COM5,211,037$44.3M2.7%−349,761−6.3%ReducedHistory
SRRKScholar Rock Holding CorpCOM5,453,083$45.4M2.7%−966,527−15.1%ReducedHistory
KYMRKymera Therapeutics, Inc.COM1,579,275$47.1M2.9%−154,814−8.9%ReducedHistory
ADCTADC Therapeutics SASHS15,269,217$48.3M2.9%00.0%UnchangedHistory
REPLReplimune Group, Inc.COM5,562,096$50.1M3.0%+1,832,113+49.1%AddedHistory
LIVNLivaNova PLCSHS929,506$51.0M3.1%−108,274−10.4%ReducedHistory
RGNXREGENXBIO Inc.COM4,569,802$53.5M3.2%+18,246+0.4%AddedHistory
IMNMImmunome Inc.COM4,889,554$59.2M3.6%00.0%UnchangedHistory
STOKStoke Therapeutics, Inc.COM4,721,054$63.8M3.9%−351,995−6.9%ReducedHistory
NRIXNurix Therapeutics, Inc.COM4,423,616$92.3M5.6%−59,400−1.3%ReducedHistory
FOLDAmicus Therapeutics, Inc.COM10,595,089$105.1M6.4%−2,662,197−20.1%ReducedHistory
KRYSKrystal Biotech, Inc.COM1,021,078$187.5M11.3%−487,172−32.3%ReducedHistory

Sold out since Q1 2024 (14)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
DCPHDeciphera Pharmaceuticals, Inc.COM5,296,643$83.3M3.1%History
ABTAbbott LaboratoriesStock262,371$29.8M1.1%History
ALGNAlign Technology IncCOM87,255$28.6M1.1%History
CICigna GroupStock65,435$23.8M0.9%History
EVHEvolent Health, Inc.CL A679,172$22.3M0.8%History
HCAHCA Healthcare, Inc.COM52,487$17.5M0.6%History
ELVElevance Health, Inc.Stock31,223$16.2M0.6%History
ICLRIcon PLCCOM36,949$12.4M0.5%History
PGNYProgyny, Inc.COM320,864$12.2M0.4%History
DGXQuest Diagnostics IncCOM83,849$11.2M0.4%History
MCKMcKesson CorpStock20,707$11.1M0.4%History
ELANElanco Animal Health IncCOM676,039$11.0M0.4%History
PENPenumbra IncCOM44,613$9.96M0.4%History
APLSApellis Pharmaceuticals, Inc.COM155,000$9.11M0.3%History